PharmaShots | Incisive News in 3 Shots

Subscribe Now

Fatty Acid Oxidation Disorder

Ultragenyx's Dojolvi (UX007/triheptanoin) Receives the US FDA's Approval to Treat Long-Chain Fatty Acid Oxidation Disorders

Ultragenyx's Dojolvi (UX007/triheptanoin) Receives the US FDA's Approval to Treat Long-Chain Fatty Acid Oxidation Disorders

June 15, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us